延长释放洛拉泽的探索:对安全护士从业人员实践的影响
Journal of psychosocial nursing and mental health services
|December 31, 2025
概括
美国食品和药物管理局批准了Loreev XR®,这是一种新的延长释放的洛拉泽帕姆配方. 这篇文章回顾了其属性,并为护士执业人员管理焦虑和失眠的安全处方考虑因素.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床药房 临床药房
背景情况:
- 二胺 (BZDs),包括洛拉泽,广泛用于治疗焦虑,失眠和压力.
- 已确定的风险包括依赖,戒断,认知障碍以及与中枢神经系统抑郁剂的相互作用.
- 执业护士 (NP) 在管理这些情况方面发挥着至关重要的作用.
研究的目的:
- 检查新延长释放的洛拉泽帕姆配方Loreev XR®的合理性.
- 为了区分其药理动力学和药理动力学特性与立即释放的洛拉泽帕姆.
- 概述国家药师对国家药师安全处方实践的影响.
主要方法:
- 对延长释放的洛拉泽帕姆的药理动力学和药理动力学数据的审查.
- 对在管理患者使用二zepinesNP临床考虑的分析.
- 强调风险评估,患者监测和基于证据的逐渐减少策略.
主要成果:
- 洛瑞夫XR®提供了2021年批准的长期起作用的洛拉泽帕姆配方.
- 了解其独特的特性对于安全有效的患者管理至关重要.
- 国家计划需要指导,如何将这种新的表述纳入实践中.
结论:
- 延长释放的洛拉泽对治疗焦虑和失眠的NP提出了新的考虑.
- 安全的处方需要对患者进行彻底的评估,风险评估和仔细的监测.
- 在确保安全的护理过渡和实施基于证据的减量协议中,NP对于二胺使用至关重要.
更多相关视频
06:59A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
31.0K
14:52Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers
Published on: January 13, 2018
11.4K
相关概念视频
Anxiolytic Drugs: Benzodiazepines and Buspirone
2.3K
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
2.3K
CNS Depressants: Barbiturates and Benzodiazepines
1.1K
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.1K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
598
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
598
Factors Affecting Drug Response: Overview
2.8K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.8K
Pharmacokinetics in Pediatric Patients: Drug Excretion
191
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
191
Sedatives and Hypnotics Drugs: Miscellaneous Agents
475
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
475
